Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
CLL 환자는 오미크론 시대에 COVID-19로 인한 사망 위험이 더 낮습니다
Article
[키워드] 30-Day mortality
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Admission
age
antiviral therapy
chronic lymphocytic leukemia
CLL
Cohort
cohort of patient
Comorbidity
Contact
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
death
declined
described
disease course
dominance
General population
high mortality
hospital
Hospitalization
hospitalizations
Immunocompromised
Immunocompromised patient
Immunocompromised patients
intensive care
leukemia
lower risk
Lymphocytic leukemia
omicron
Omicron variant
outcome
Patient
population-based cohort
positive
Previous studies
previous study
remained
reported
SARS-CoV-2
SARS-CoV-2 test
severe acute respiratory syndrome Coronavirus
shown
significantly
tested
variant
[DOI] 10.1182/blood.2022016147 PMC 바로가기 [Article Type] Article
[DOI] 10.1182/blood.2022016147 PMC 바로가기 [Article Type] Article